| Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab … F Bibeau, E Lopez-Crapez, F Di Fiore, S Thezenas, M Ychou, F Blanchard, ... Journal of clinical oncology 27 (7), 1122-1129, 2009 | 611 | 2009 |
| Oestrogen receptor negative breast cancers exhibit high cytokine content C Chavey, F Bibeau, S Gourgou-Bourgade, S Burlinchon, F Boissière, ... Breast Cancer Research 9, 1-11, 2007 | 437 | 2007 |
| An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease MG Murer, F Boissiere, Q Yan, S Hunot, J Villares, B Faucheux, Y Agid, ... Neuroscience 88 (4), 1015-1032, 1999 | 230 | 1999 |
| Nuclear translocation of NF-κB in cholinergic neurons of patients with Alzheimer's disease F Boissière, S Hunot, B Faucheux, C Duyckaerts, JJ Hauw, Y Agid, ... Neuroreport 8 (13), 2849-2852, 1997 | 188 | 1997 |
| Proteomics-Based Identification of HSP60 as a Tumor-Associated Antigen in Early Stage Breast Cancer and Ductal Carcinoma in situ C Desmetz, F Bibeau, F Boissiere, V Bellet, P Rouanet, T Maudelonde, ... Journal of proteome research 7 (9), 3830-3837, 2008 | 154 | 2008 |
| FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell S Relier, J Ripoll, H Guillorit, A Amalric, C Achour, F Boissière, J Vialaret, ... Nature communications 12 (1), 1716, 2021 | 118 | 2021 |
| Increased expression of class III β-tubulin in castration-resistant human prostate cancer S Terry, G Ploussard, Y Allory, N Nicolaiew, F Boissiere-Michot, P Maille, ... British journal of cancer 101 (6), 951-956, 2009 | 117 | 2009 |
| Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease F Boissiere, B Faucheux, M Ruberg, Y Agid, EC Hirsch Experimental neurology 145 (1), 245-252, 1997 | 108 | 1997 |
| TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy A Oden-Gangloff, F Di Fiore, F Bibeau, A Lamy, G Bougeard, ... British journal of cancer 100 (8), 1330-1335, 2009 | 97 | 2009 |
| Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma S Paillas, F Boissière, F Bibeau, A Denouel, C Mollevi, A Causse, V Denis, ... Cancer research 71 (3), 1041-1049, 2011 | 93 | 2011 |
| Characterization of an adaptive immune response in microsatellite-instable colorectal cancer F Boissière-Michot, G Lazennec, H Frugier, M Jarlier, L Roca, J Duffour, ... Oncoimmunology 3 (6), e29256, 2014 | 91 | 2014 |
| Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease S Hunot, V Bernard, B Faucheux, F Boissiere, E Leguern, C Brana, ... Journal of neural transmission 103, 1043-1052, 1996 | 80 | 1996 |
| Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies Y Ashraf, H Mansouri, V Laurent-Matha, LB Alcaraz, P Roger, S Guiu, ... Journal for Immunotherapy of Cancer 7, 1-17, 2019 | 79 | 2019 |
| Prognostic value of HER2-low expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers W Jacot, A Maran-Gonzalez, O Massol, C Sorbs, C Mollevi, S Guiu, ... Cancers 13 (23), 6059, 2021 | 78 | 2021 |
| Efficient DNA electrotransfer into tumors M Bettan, MA Ivanov, LM Mir, F Boissiere, P Delaere, D Scherman Bioelectrochemistry 52 (1), 83-90, 2000 | 78 | 2000 |
| Proteomic analysis of RCL2 paraffin‐embedded tissues V Bellet, F Boissiere, F Bibeau, C Desmetz, ML Berthe, P Rochaix, ... Journal of cellular and molecular medicine 12 (5b), 2027-2036, 2008 | 71 | 2008 |
| Tyrosine kinase B messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study S Benisty, F Boissiere, B Faucheux, Y Agid, EC Hirsch Neuroscience 86 (3), 813-826, 1998 | 71 | 1998 |
| Sorafenib and irinotecan (NEXIRI) as second-or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial E Samalin, O Bouche, S Thézenas, E Francois, A Adenis, J Bennouna, ... British journal of cancer 110 (5), 1148-1154, 2014 | 69 | 2014 |
| Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization A Ho-Pun-Cheung, C Bascoul-Mollevi, E Assenat, F Boissière-Michot, ... BMC molecular biology 10, 1-10, 2009 | 64 | 2009 |
| Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray F Bibeau, F Boissière-Michot, JC Sabourin, S Gourgou-Bourgade, ... Virchows Archiv 449, 281-287, 2006 | 64 | 2006 |
